• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测癫痫患者丙戊酸血清稳态浓度的单剂量模型。

Single-dose model for predicting steady-state valproic acid serum concentrations in seizure patients.

作者信息

Pugh C B, Garnett W R, Poynor W J, Pellock J M

出版信息

Clin Pharm. 1984 Nov-Dec;3(6):643-9.

PMID:6439455
Abstract

Valproic acid serum concentrations predicted by a single-dose prediction model were compared with steady-state serum concentrations measured after the start of therapy in seizure patients. Ten patients receiving valproic acid for the first time or who had not been taking the drug for two or more weeks were entered into the study. The patients' therapies were initiated with the prescribed doses of valproic acid and then maintained on fixed doses and dosing intervals until steady-state trough serum samples were obtained. Initial 5-ml blood samples were collected six to 14 hours after the ingestion of the first dose; a 5-ml steady-state trough sample was drawn in the same manner three to seven days later. Both free and total drug concentrations were determined within 48 hours of sample collection using gas-liquid chromatography. The elimination rate constant was estimated from age-specific population half-life values found in the literature. Six patients (five children, aged four to 16 years) and one adult (aged 87 years) completed the study. There was a statistically significant correlation between predicted and measured steady-state valproic acid serum concentrations for both free and total concentrations. The single-dose prediction model accurately predicted steady-state valproic acid serum concentrations in these seizure patients.

摘要

将单剂量预测模型预测的丙戊酸血清浓度与癫痫患者开始治疗后测得的稳态血清浓度进行比较。10例首次接受丙戊酸治疗或已停药两周或更长时间的患者进入该研究。患者的治疗开始时给予规定剂量的丙戊酸,然后维持固定剂量和给药间隔,直至获得稳态谷血清样本。首次给药后6至14小时采集初始5毫升血样;3至7天后以相同方式采集5毫升稳态谷样本。在样本采集后48小时内使用气液色谱法测定游离和总药物浓度。消除速率常数根据文献中特定年龄的群体半衰期值估算。6例患者(5名儿童,年龄4至16岁)和1名成人(87岁)完成了研究。游离和总浓度的预测稳态丙戊酸血清浓度与实测浓度之间存在统计学显著相关性。单剂量预测模型准确预测了这些癫痫患者的稳态丙戊酸血清浓度。

相似文献

1
Single-dose model for predicting steady-state valproic acid serum concentrations in seizure patients.预测癫痫患者丙戊酸血清稳态浓度的单剂量模型。
Clin Pharm. 1984 Nov-Dec;3(6):643-9.
2
Prediction of steady-state concentrations of valproic acid as determined from single plasma concentrations after the first dose.
Clin Pharm. 1983 Mar-Apr;2(2):143-7.
3
Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children.癫痫患儿中总丙戊酸和游离丙戊酸的药代动力学参数及其与癫痫控制的关系。
Am J Ther. 2006 May-Jun;13(3):211-7. doi: 10.1097/01.mjt.0000155113.89092.58.
4
Inverse correlation of valproic acid serum concentrations and quality of life in adolescents with epilepsy.癫痫青少年丙戊酸血清浓度与生活质量的负相关
Epilepsy Res. 2008 Aug;80(2-3):180-3. doi: 10.1016/j.eplepsyres.2008.04.006. Epub 2008 May 20.
5
Single dose and steady state pharmacokinetics of valproic acid in adult epileptic patients.
Int J Clin Pharmacol Res. 1991;11(3):137-41.
6
Interactions of serum albumin, valproic acid and carbamazepine with the pharmacokinetics of phenytoin in cancer patients.血清白蛋白、丙戊酸和卡马西平与癌症患者中苯妥英钠药代动力学的相互作用。
Basic Clin Pharmacol Toxicol. 2006 Aug;99(2):133-40. doi: 10.1111/j.1742-7843.2006.pto_309.x.
7
[Problems in serum-level determination during valproic acid therapy].[丙戊酸治疗期间血清水平测定的问题]
Arzneimittelforschung. 1977;27(6):1215-21.
8
High unbound fraction of valproic acid in a hypoalbuminemic critically ill patient on renal replacement therapy.低蛋白血症危重症患者在行肾脏替代治疗时,丙戊酸的结合率低。
Ann Pharmacother. 2011 Mar;45(3):e18. doi: 10.1345/aph.1P308. Epub 2011 Feb 15.
9
Pharmacokinetic study of valproic acid in a neonate.丙戊酸在一名新生儿中的药代动力学研究。
Pediatr Pharmacol (New York). 1982;2(4):317-21.
10
Different serum concentrations of steady-state valproic acid in two sustained-release formulations.
Psychiatry Clin Neurosci. 2007 Jun;61(3):308-12. doi: 10.1111/j.1440-1819.2007.01656.x.

引用本文的文献

1
Clinical pharmacokinetics of valproic acid--1988.丙戊酸的临床药代动力学——1988年
Clin Pharmacokinet. 1988 Dec;15(6):367-89. doi: 10.2165/00003088-198815060-00002.